93 related articles for article (PubMed ID: 7511287)
1. [Morphometric, cytochemical and immunohistochemical studies on the proliferative activity of urinary bladder carcinomas].
Krüger S; Kahl M; Fabian T; Hörlin A; Herrmann G; Müller H; Schneider M
Verh Dtsch Ges Pathol; 1993; 77():231-5. PubMed ID: 7511287
[TBL] [Abstract][Full Text] [Related]
2. Correlation of morphometry, nucleolar organizer regions, proliferating cell nuclear antigen and Ki67 antigen expression with grading and staging in urinary bladder carcinomas.
Krüger S; Müller H
Br J Urol; 1995 Apr; 75(4):480-4. PubMed ID: 7788260
[TBL] [Abstract][Full Text] [Related]
3. [Monoclonal antibodies (MIB 1, PC 10, 486p and p53) as prognostic factors for recurrent urothelial carcinoma of the urinary bladder].
Hake R; Vorreuther R; Borchmann P; Lukowsky S; Thiele J; Fischer R
Verh Dtsch Ges Pathol; 1993; 77():236-40. PubMed ID: 7511288
[TBL] [Abstract][Full Text] [Related]
4. Role of the argyrophilic nucleolar organizer regions in tumor detection and prognosis.
Pich A; Chiusa L; Margaria E
Cancer Detect Prev; 1995; 19(3):282-91. PubMed ID: 7750118
[TBL] [Abstract][Full Text] [Related]
5. [The malignancy potential of colorectal polyps--histomorphometric, histochemical and immunohistochemical study of the dysplasia-carcinoma sequence].
Dippe B; Petrowsky H; Krüger S; von Jentzkowski K; Schneider M; Lorenz M
Zentralbl Chir; 1995; 120(7):556-63. PubMed ID: 7676754
[TBL] [Abstract][Full Text] [Related]
6. Cell proliferation in colorectal adenomas containing invasive carcinoma.
Risio M; Rossini FP
Anticancer Res; 1993; 13(1):43-7. PubMed ID: 8097391
[TBL] [Abstract][Full Text] [Related]
7. Cell proliferation indices, morphometry and DNA flow cytometry provide objective criteria for distinguishing low and high grade bladder carcinomas.
Pich A; Chiusa L; Comino A; Navone R
Virchows Arch; 1994; 424(2):143-8. PubMed ID: 7910097
[TBL] [Abstract][Full Text] [Related]
8. Proliferating cell nuclear antigen expression and argyrophilic nucleolar organizer regions as factors influencing prognosis of surgically treated lung cancer patients.
Ishida T; Kaneko S; Akazawa K; Tateishi M; Sugio K; Sugimachi K
Cancer Res; 1993 Oct; 53(20):5000-3. PubMed ID: 8104690
[TBL] [Abstract][Full Text] [Related]
9. Proliferative activity is a significant prognostic factor in male breast carcinoma.
Pich A; Margaria E; Chiusa L
Am J Pathol; 1994 Aug; 145(2):481-9. PubMed ID: 7519830
[TBL] [Abstract][Full Text] [Related]
10. Use of proliferative markers Ki-67 (MIB-1) and proliferating cell nuclear antigen (PC10) in transitional cell carcinoma of the renal pelvis.
Cheville JC; Terrell RB; Cohen MB
Mod Pathol; 1994 Sep; 7(7):794-800. PubMed ID: 7824516
[TBL] [Abstract][Full Text] [Related]
11. Proliferative activity is the most significant predictor of recurrence in noninvasive papillary urothelial neoplasms of low malignant potential and grade 1 papillary carcinomas of the bladder.
Pich A; Chiusa L; Formiconi A; Galliano D; Bortolin P; Comino A; Navone R
Cancer; 2002 Aug; 95(4):784-90. PubMed ID: 12209722
[TBL] [Abstract][Full Text] [Related]
12. [Analysis of proliferating cell nuclear antigen and nucleolar organizer region in testicular tumors].
Kurisu H; Shimabukuro T; Wada T; Yamamoto M; Shameem IA; Otsuka T; Sakano S; Matsuyama H; Naito K; Yamamoto N
Hinyokika Kiyo; 1993 Aug; 39(8):715-20. PubMed ID: 8104387
[TBL] [Abstract][Full Text] [Related]
13. [A comparison of proliferating cell nuclear antigen immunostaining, nucleolar organizer region staining in lung cancer].
Zhao T; Zhang YL; Li CD
Zhonghua Jie He He Hu Xi Za Zhi; 1993 Dec; 16(6):342-4, 374. PubMed ID: 7913415
[TBL] [Abstract][Full Text] [Related]
14. Expressions of proliferation markers (Ki-67, proliferating cell nuclear antigen, and silver-staining nucleolar organizer regions) and of p53 tumor protein in gestational trophoblastic disease.
Kale A; Söylemez F; Ensari A
Am J Obstet Gynecol; 2001 Mar; 184(4):567-74. PubMed ID: 11262454
[TBL] [Abstract][Full Text] [Related]
15. [Comparative studies on the biological significance of the marker for proliferation Ki-67-Antigen and PCNA in primary ovarian carcinoma].
Reitmaier M; Rudlowski C; Biesterfeld S; Rath W; Schröder W
Zentralbl Gynakol; 2000; 122(7):361-7. PubMed ID: 10951706
[TBL] [Abstract][Full Text] [Related]
16. Renal cell (Grawitz) carcinoma: an immunohistochemical study in correlation with nuclear grade, histological pattern and proliferative activity of tumor cells.
Nagar C; Tralongo V; Morello V; Salvato M; Curti Giardina M; Latteri MA; Nuara R; Arena N; Vita C; Orestano F
Pathologica; 1993; 85(1097):343-52. PubMed ID: 7694227
[TBL] [Abstract][Full Text] [Related]
17. [Proliferative activity and p53 expression in transitional cell carcinoma of the urinary bladder].
Offner FA; Schäfer G; Hittmair A; Ofner D; Grünewald K; Weyrer K; Mattern D; Eberle J; Mikuz G; Feichtinger H
Verh Dtsch Ges Pathol; 1993; 77():241-6. PubMed ID: 7511289
[TBL] [Abstract][Full Text] [Related]
18. [Growth fractions of bladder cancer determined by proliferating cell nuclear antigen immunostaining].
Kuroda H; Yasunaga Y; Takatera H; Fujioka H; Ohnishi A; Tsujimoto M
Hinyokika Kiyo; 1994 May; 40(5):379-82. PubMed ID: 7912881
[TBL] [Abstract][Full Text] [Related]
19. PCNA/cyclin expression in transitional cell carcinomas of the human bladder: its correlation with Ki-67 and epidermal growth factor receptor immunostainings.
Serio G
Pathologica; 1994 Apr; 86(2):161-6. PubMed ID: 7936759
[TBL] [Abstract][Full Text] [Related]
20. Bilharzial related, organ confined, muscle invasive bladder cancer: prognostic value of apoptosis markers, proliferation markers, p53, E-cadherin, epidermal growth factor receptor and c-erbB-2.
Haitel A; Posch B; El-Baz M; Mokhtar AA; Susani M; Ghoneim MA; Marberger M
J Urol; 2001 May; 165(5):1481-7. PubMed ID: 11342901
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
